ADCT
ADC Therapeutics SA
1.30$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -253.0% | -195.0% | -244.3% | -188.7% | -135.6% | -129.2% | -244.6% | -127.9% | -180.4% | -135.0% | -148.3% | -61.3% | -129.8% | |
| 6.1% | 9.2% | 4.7% | 4.8% | 4.3% | 4.7% | 3.5% | 6.3% | 0.7% | 0.5% | 0.6% | 5.5% | 1.8% | |
| 14.4% | 13.2% | 0.9% | 11.4% | 15.2% | 9.6% | 10.5% | 9.6% | 12.2% | 26.6% | 12.2% | 23.6% | 19.2% | |
| 88.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -3.2% | 59.6% | -55.0% | -27.7% | 46.3% | 59.3% | -128.1% | 81.5% | 2.4% | -51.5% | -25.0% | 56.8% | -7.0% | |
| 4.6% | 1.9% | 2.9% | 0.2% | 1.2% | 0.5% | 1.1% | 0.1% | 0.0% | 0.1% | 0.2% | 0.0% | 0.1% | |
| -4.6% | -3.0% | -2.9% | -0.2% | -1.2% | -0.5% | -1.1% | -0.1% | 0.0% | 3.0% | -0.2% | 0.0% | 0.8% | |
| – | 0.0% | – | – | – | -6.9% | 0.0% | -1.3% | – | – | -0.1% | 0.0% | – | |
| -2.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.4% | 6.2% | 2.0% | 566.9% | -4.8% | -6.6% | 1.2% | 497.8% | -1.2% | 252.4% | -2.9% | -0.5% | 72.8% | |
| -256.0% | -189.5% | -245.5% | 378.1% | -140.0% | -138.4% | -243.9% | 370.8% | -181.5% | 115.4% | -151.4% | -61.9% | -57.7% | |
| -257.6% | -197.0% | -247.2% | -188.8% | -136.8% | -129.8% | -245.7% | -127.9% | -180.4% | -135.0% | -148.5% | -61.3% | -129.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.